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Abstract
Background: After introduction of the concept of critical value (CV) in laboratory medicine,
some efforts were performed to define possible critical values in surgical pathology. Critical
diagnosis (critical value) is a concept recently established in surgical pathology and is a challenging
issue among pathologists and clinical specialists. The concept may be the subject of variation
according to the geographical or work setting differences. The current study was performed to
bring the contribution of the Iranian pathologists to the evolving concept of critical diagnoses
(critical values) in surgical pathology.
Materials and methods: During annual meeting of Iranian Pathologist Society, November 2006,
Tehran, Iran, anonymous questionnaires were distributed among participants. They were
requested to openly name conditions in which a pathologist should communicate the results
immediately with clinicians.
Results: 147 pathologists completed the questionnaire. They were varied in their level of
experience and setting of workplace. Each participant referred to 1–7 (mean 3) conditions as CV.
About 90 different conditions which were considered as CV by participants were extracted from
the questionnaires.
Discussion: The list of conditions obtained through this survey as CVs in surgical pathology
covered most items previously described in literature. Major differences are low number (or lack)
of refers to some relatively routine and potentially important conditions and considering many
unimportant conditions as CV by participants of present survey. Almost all conducted surveys have
been performed on this issue so far (including the present survey) suffer from lack of supportive
scientific evidences and based mainly on experience and common sense of participants in survey.
Potential problems with application of CV concept in daily routine work flow of pathology,
particularly in developing countries like Iran, were discussed.
Background
The concept of critical value (CV) was introduced for first
time in 1972 by Lundberg [1]. He defined the situation as
"a pathophysiologic derangement at such variance with
normal as to be life threatening if therapy is not instituted
immediately". This concept is very understandable in clin-
ical laboratory settings when physicians are working with
"numerical" data. Accordingly very clear cutoffs can be
defined which are discriminative between life threatening
emergency situations and those that can be handled in the
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ples of CVs in clinical laboratory is critically low levels of
serum potassium which threats life by imposing patient to
danger of cardiac arrhythmias and hence mandates imme-
diate intervention. The question emerged thereafter about
the possible presence of similar conditions in surgical
pathology. As a discipline integrated in the field of labora-
tory diagnosis the presence of CVs in surgical pathology is
expectable. But in contrast to clinical laboratory, surgical
pathologists are engaged with "interpretation" rather than
"number". In most instances surgical pathologists rely on
their experience and common sense to consider a patho-
logic process as a CV. For considering a condition as CV in
surgical pathology one important characteristic should be
taken into account: it is potentially life threatening if any
delay happens in diagnosis and communicating the
results with clinicians. At least in developing or underde-
veloped countries implementation of CV concept in prac-
tice needs much investment in equipment and dramatic
changes in specimen handling. Accordingly at first step it
is necessary to realize how pathologists conceptualize the
CV in surgical pathology and which conditions they find
necessary to immediate interaction. In this study a survey
was conducted to assess the viewpoint of Iranian patholo-
gists about the CVs in surgical pathology and to find out
how close or far their ideas from their peers in developed
countries, using ADASP guidelines as a base for compari-
son.
Methods
During annual meeting of members of Iranian Patholo-
gists Society, November 2006, Tehran, Iran, anonymous
questionnaires were distributed among participants. In
addition to general and demographic data, the partici-
pants were requested to openly notify five situations in
which they think it is necessary to inform clinicians
immediately about the results of surgical pathology spec-
imens' evaluation without any delay for completion of
routine process. Exact phrases in questionnaire are "
Please name five clinical situation, pathologic diagnoses,
or specific findings in microscopic or macroscopic evalu-
ation of pathology specimens that when you encountered,
you find it necessary to call the attending physician and
communicate the findings immediately, before waiting
for completion of routine process of pathology report
preparation. On the other word which situations in surgi-
cal pathology seems to you as critical situations." The
answers were extracted from questionnaires, tabulated
and compared with available previous studies.
Results
147 pathologists filled the questionnaire. They included
81 males and 60 females with age ranging 25–67 (mean
39.5) years. In 6 questionnaires the sex of participant was
not identified. Participants are various in the level of edu-
cation and experience and their workplace setting. Three
of the participants were pathology assistants, all were in
year 4 of postgraduate study. 41 participants were mem-
bers of scientific boards of universities (38 assistant and 1
associated Professor) with 1–24 (mean 8.5) years of expe-
rience. Two scientific board members did not identify
their scientific grade. 91 participants were not member of
scientific board with 1–30 (mean 6.9) years of experience.
Most participants were working only in university hospi-
tals (39), followed by non-university hospitals (26) and
private outpatient laboratory (24). 45 participants were
working in two settings at a same time. The frequent com-
binations were university hospital and private outpatient
lab (18), non-university hospital and private outpatient
laboratory (25) and university and non-university hospi-
tal laboratories (2). In 11 questionnaires the workplace
setting were not identified.
In addition to 3 assistants, 27 of participants were only
responsible for clinical laboratory at the time they
responded the questionnaire and were not signing out any
surgical pathology specimen in their workplace. Since
pathology assistants study in both fields of surgical and
clinical pathology in Iran, the answers of these partici-
pants were taken into account, too. Among the other par-
ticipants the number of cases each pathologist were
responsible for directly, varied from 20 to 6000 in each
year (mean 1336).
In each questionnaire from 1 to 7 (mean 3) conditions
were notified by participants as CVs. About 90 different
conditions were named by participants as critical values in
surgical pathology (table 1). The number of times each
condition was referred was ranged from 1 to 52. The most
frequently referred situation was acute leukemia in bone
marrow sampling (52) followed in decreasing order by
reports of intraoperative consultation (26), unexpected
malignancy in any specimens (23), and mucor mycosis
(12). High grade lymphomas and insufficient or absent
specimen were referred 9 times. Breast malignancies (with
no further qualification) were referred as a critical value 7
times. Malignancy in endoscopic biopsy specimens,
malignancy in fine needle aspiration of tissues, and malig-
nant melanoma were referred 6 times. Among the condi-
tions which were referred more than one time but less
than 6 times, noticeable conditions include malignant
cells in cytology of fluids (5), unexpected benignancy (5),
any difference between interpretation of present evalua-
tion and previous pathologic diagnosis (4), necrotizing
vasculitis (4), renal needle biopsy in transplanted kidney
(3), mediastinal lymphoblastic lymphoma (3), septic
arthritis (3), any mediastinal mass in patients with supe-
rior vena cava syndrome (3), Burkitt's lymphoma (2),
diagnostic curettage in suspected ectopic pregnancy cases
(2), margins involvement in resection specimens ofPage 2 of 5
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phritis (2), and infectious agents in immunocompro-
mised patients (2). About 45 conditions were referred
only once by participants. Some noticeable conditions
among them are: diagnostic curettage in patients sus-
pected to malignancy, discordance between clinical and
pathologic diagnosis, false sampling in confirming biop-
sies (tubal ligation, vagotomy, vasectomy, etc), temporal
arteritis, and transplant rejection.
Discussion
"Critical value" is a well known concept in clinical pathol-
ogy laboratory. It has been defined as quantitative levels
of analytes in any body fluids (particularly in serum)
which impose patients directly or indirectly to life threat-
ening consequences, and hence needs rapid communica-
tion with physician and immediate intervention. The
most usual examples in daily practice are very high or very
low levels of serum potassium.
In surgical pathology the situation is very different from
clinical laboratory setting. Surgical pathology reports'
contents are usually in the form of "interpretations". Very
rarely "numerical data" can be found in surgical pathol-
ogy report and if they can, most often are indicators of
grading or staging of a benign inflammatory (viral hepati-
tis) or malignant neoplastic process. Hence critical values
in surgical pathology cannot be defined by "cutoffs". In
addition most critical values in surgical pathology are
those which depend on the clinical variables and condi-
tion of patient. For instance absence of chorionic villi, tro-
phoblastic cells and embryonal tissue in an endometrial
curettage can be considered critical only when the patient
was suspected to be pregnant. Accordingly the more
appropriate term might be "critical diagnoses" rather than
"critical values". Such limitations hampered precise defi-
nition of CV in surgical pathology. On the other hand if
in a clinical situation the problem of time plays a critical
role, one of routine approaches is intraoperative consulta-
tion and frozen section examination. One can postulate
that CVs in surgical pathology are those conditions which
cannot be managed by frozen section examination. These
are among the reasons why defining CV in surgical pathol-
ogy is not straightforward and why the pathology litera-
ture including pathology textbooks are very poor on this
issue.
One of the rare studies performed to define CVs in surgical
pathology is a survey performed by Pereira and colleagues
[2]. According to their personal experience they provided
a list of 11 conditions which considered being critical val-
ues in surgical pathology. Then they presented the list to a
group of 11 pathologists and 5 clinical specialists and
asked them to grade the situations as a CV in a four tier
scale according to the level of urgency for communication
with clinicians. The situations included crescents in kid-
ney biopsy specimen, vasculitis, bacteria in heart valve or
bone marrow, organisms in an immunocompromised
patient, fat in an endometrial curettage specimen, uterine
contents without villi or trophoblasts in the workup of a
patient suspected to be pregnant, mesothelial cells in a
heart biopsy specimen, transplant rejection, malignancy
in superior vena cava syndrome, neoplasms potentially
causing paralysis, and large vessels in a core biopsy speci-
men. Additional situations were added by participants to
the above list. Participating pathologists added unex-
pected malignancy, disagreement between frozen section
and permanent diagnoses, all fine-needle aspirations per-
formed by a pathologist, fat in snare of biopsies of a colon
polyp, polyomavirus in urine cytologic specimen, hyda-
tidiform mole, hemophagocytic syndrome, necrotizing
fasciitis, staphylococcal scalded skin syndrome, and vari-
ous hematologic malignant neoplasms such as acute
leukemia (also listed specifically as acute myelogenous
leukemia, French-American-British type M3), Burkitt lym-
phoma, and leukemia cutis. The additional diagnoses
listed by clinicians were unexpected malignancy, change
of diagnosis in inflammatory bowel disease (from Crohn
Table 1: Most common conditions considered as CV by 
participants of present survey. 
Conditions Number of Refers





High grade lymphomas 9
Unsuitable or absent specimen 9
Breast malignancy 7
Malignancy in endoscopic specimens 6
Malignancy in FNA 6
Malignant melanoma 6
Brain Tumors 5
CIN II and III 5
Malignant cells in cytology of fluids 5
Tuberculosis 5
Unexpected Benignancy 5
Bone marrow biopsy for thrombocytopenia 4
Difference with previous pathologic diagnosis 4
Necrotizing vasculitis 4
Renal needle biopsy in transplanted kidney 4
CSF cytology with malignant or leukemic cells 3
Cutaneous vesiculo-bullous diseases 3
Fluid cytology 3




Mediastinal mass in SVC syndrome 3
Second column numbers depict how many times the condition was 
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in a tissue biopsy specimen (eg, lymph nodes), and inva-
sive aspergillosis or fungi in the nasal sinus or lung.
The same group of scientists later conducted another sur-
vey for evaluation of critical values in cytology [3]. Critical
value conditions which presented for scaling to partici-
pants were unexpected malignancy, disagreement
between preliminary and final fine-needle aspiration
diagnoses, and organisms in nongynecologic and fine-
needle aspiration specimens. Additional CV cases sug-
gested by the survey participants included herpes in a Pap
smear in a pregnant patient, atypical glandular cells of
uncertain significance in Pap smears, amended reports,
very unusual tumors, disagreement with outside slide
interpretation, infection or malignancy in orbital fine-
needle aspiration samples, discrepancy between clinical
expression and pathologic interpretation, and delay in
signing out the cytology report.
Considering the long list of conditions mentioned by par-
ticipants in the present survey (about 90 conditions), it is
not surprising that many of conditions which has been
discussed in two surveys of Pereira et al were mentioned
by participants of present survey, too. But there are some
concerns about the viewpoint of present survey partici-
pants. The first is the large number of refers to conditions
which they are not included in the Pereira studies and
rationally cannot be considered as a CV. Such conditions
include breast malignancy (9), malignancy in all endo-
scopic specimens (6), malignant melanoma (6), brain
tumors (6), and CIN II and III (5). The second is very low
number of refers to the conditions which are considered
as CV in the Pereira studies. Such conditions include diag-
nostic curettage in suspected ectopic pregnancy (2) and
presence of crescents in kidney biopsy specimens (2).
There are some important conditions in the Pereira stud-
ies which were never mentioned by participants in present
survey. These include bacteria in heart valve or bone mar-
row, organisms in an immunocompromised patient, fat
in an endometrial curettage specimen, mesothelial cells in
a heart biopsy specimen, large vessels in a core biopsy
specimen, fat in snare of biopsies of a colon polyp, and
acid-fast bacilli in a tissue biopsy specimen. Although
many of these conditions are rare in general pathology
laboratories and are only encountered in specific situa-
tions (e.g. mesothelial cells in heart muscle biopsy), many
of them are among the conditions that may happen in
every general hospital pathology laboratory (e.g. fat in
endometrial curettage, fat in the snare of biopsies of
colonic polyps, or large vessels in needle biopsy speci-
mens). This comparison shows that the general knowl-
edge about the critical values in surgical pathology is poor
among pathologists community. One of the reasons may
be the rarity of documents covering this important issue
in pathology literature. Dedication of a book chapter or
appendices of textbooks to this topic can definitely attract
attention of under or post graduate pathologist to this
important topic.
To fill this gap in our knowledge, in 2006 the Association
of Directors of Anatomical and Surgical Pathology
(ADASP) provided a list of CVs in surgical pathology [4-
6]. Based on the survey among ADASP members, the fol-
lowing conditions were extracted and categorized under
three different headings. Group one is conditions that
have immediate clinical consequences. This group
includes crescents in greater than 50% of glomeruli in a
kidney biopsy, leukocytoclastic vasculitis, uterine con-
tents without villi or trophoblast, fat in an endometrial
curettage, mesothelial cells in a heart biopsy, fat in colonic
endoscopic polypectomies, transplant rejection, malig-
nancy in superior vena cava syndrome, and neoplasms
causing paralysis. The second group is composed of con-
ditions in which there are unexpected or discrepant find-
ings. This group includes significant disagreement
between frozen section and final diagnosis, significant
disagreement between immediate interpretation and final
FNA diagnosis, unexpected malignancy, and significant
disagreement and/or change between primary pathologist
and outside pathologist consultation (at either the origi-
nal or consulting institution). The third group is consti-
tuted by infectious conditions. They include bacteria or
fungi in CSF cytology in immunocompromised or immu-
nocompetent patients, pneumocystis, fungi or viral cyto-
pathic changes in bronchoalveolar lavage (BAL),
bronchial washing or brushing cytology specimens in
immunocompromised or immunocompetent patients,
acid-fast bacilli in immunocompromised or immuno-
competent patients, fungi in FNA of immunocompro-
mised patients, bacteria in heart valve or bone marrow,
herpes in Pap smears of near term pregnant patients, and
any invasive organism in surgical pathology specimens of
immunocompromised patients. ADASP committee has
emphasized that the above list would be considered only
as a template and each institute should define their list
individually and by cooperation with clinical colleagues.
They also commented to avoid overuse of this terminol-
ogy.
Preparation of the template table by ADASP members is a
step forward in the issue of critical values in surgical
pathology, but it seems insufficient. Many questions and
problems remained unsolved in this issue and deserve
more attention.
▪ Are pathologists responsible for defining critical val-
ues in surgical pathology? It seems clear that "critical
value" concept belongs to the pathologist and is their con-
cern. But are they eligible to define CVs? As ADASP com-Page 4 of 5
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pathology should be discussed with clinicians. As the
main "client" of pathology services clinicians have the
right to define their expectations and clarify conditions
they are in need of immediate communication with
pathologists for the sake of better patients' management.
From this viewpoint clinical specialty societies have a
greater responsibility in defining CVs in surgical pathol-
ogy.
▪ Are defined CV conditions in surgical pathology sup-
ported by scientific evidence? As a matter of fact most
participating scientists in the Pereira and ADASP surveys
considered a condition as a CV in surgical pathology,
largely according to their experience. It seems that none of
surveys tried to critically search for supportive or non-sup-
portive documents. Accordingly almost all the listed con-
ditions in the ADASP recommendation could be
potentially a subject of research. Studies should be con-
ducted by pathologists to clarify much vagueness in CV
concept in surgical pathology. As described before, the key
feature of a CV in surgical pathology is that any delay in
diagnosis or communicating results with clinicians has
grave consequences for patients. For each CV in surgical
pathology well designed studies should verify such a
potential threat in an "evidence based" approach.
▪ How the concept of "critical values" in surgical pathol-
ogy should change the pathology laboratories work-
flow? Is it sufficient for pathologists to only communicate
the results rapidly with clinicians? For instance if we
accept that every endometrial curettage sampling can
potentially be accompanied by threat of uterine wall
piercing and hence presence of fat in these samples might
be the first clue to this life threatening complication, any
delay in processing and reporting may adversely affect
patient's safety. It seems unwise to process the tissue in
ordinary timetable of pathology laboratory, review the
prepared slide 24–48 hours later, spend another 24 hours
for submission of remaining tissue or preparation of re-
cuts and then report the presence of fat in curettage con-
tent 48–72 hours after submission of specimen. It is clear
that rapid communication with the surgeon after this vital
gap has little, if any, effect on lowering patients' morbidity
or mortality. In such situations complete submission of
tissue immediately after receiving, fixing and processing
the tissue by rapid processing systems, and preparation of
multiple cuts are necessary changes of policy that surgical
pathology laboratories' directors should consider. In fact
in developed countries many of such changes has been
done before. Achievements in technology of tissue
processing and advent of automatic routine, specific
chemical and Immunohistochemical staining procedures
along with their application in routine practice have
reduced turnaround time within pathology laboratories.
Centralization helps in reducing costs. Communication
facilities, appropriate programming, and sophisticated
hospital and laboratory information systems, make
immediate communication of pathology results in CV
conditions very easy. Usually it is accomplished by few
key strokes and minor modifications in information sys-
tem. During recent years application of digital imaging in
routine surgical pathology diagnosis and access to telepa-
thology services have increased the speed and accuracy of
diagnosis [7]. But what is the situation in developing
countries like Iran? In contrast with developed countries
specimen handling and processing methods are tradi-
tional and communication systems including laboratory
and hospital information systems are not ideal. Almost
always the results are not accessible by physicians before
it is printed on paper and patient or his/her relatives
deliver it to the physician. In such condition the only way
of rapid communication is calling physician. Most pathol-
ogy laboratories are small and medium sized with annual
case numbers rarely reach 4000–6000. Lack of centraliza-
tion and poor resources makes investment in modern
facilities very difficult for most laboratories. Although pre-
vious studies showed that application of telepathology by
still images can help in more accurate diagnosis, it had lit-
tle effect in reducing turnaround time [8]. Hence suffi-
cient supportive evidences and thorough cost-effect
analyses are needed, before any changes in strategy are
seriously considered. Every change would be rationalized
before. This magnifies the importance of evidence based
approach to the issue of CV in surgical pathology.
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